Testimony
Testimony on Making Medicines More Affordable Through Competition
April 16, 2026
Featured Experts: Ryan Long
Research
All Research Featured Research
Comment Letter
Comments on Improving Transparency into Pharmacy Benefit Manager Fee Disclosure
April 15, 2026
Featured Experts: Geoffrey Joyce, PhD, Neeraj Sood, PhD
Perspective
Washington Is on the Verge of True PBM Reform
April 6, 2026
Featured Experts: Neeraj Sood, PhD
News
New Financing Models May Expand Access to Life-Changing Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
White Paper
High-Stakes Medicine: Rethinking Policies for the Cost and Value of Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
Perspective
The Case for Expanding Access to Weight-Loss Medications
March 12, 2026
Featured Experts: Alison Sexton Ward, PhD
Comment Letter
Comments on Proposed GLOBE and GUARD Models
February 27, 2026
Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
Perspective
Trump Admin Takes Pro-Patient Approach to Drug Prices
February 26, 2026
Featured Experts: Joseph Grogan, JD
Journal Article
Cost-Effectiveness of Gene Therapy for Sickle Cell Disease in Uganda: Tailoring High-Income Evidence to Uganda’s Context
February 26, 2026
Featured Experts: J. Felipe Montano-Campos, PhD
News
Schaeffer Research Helps Reshape Federal Oversight of Pharmacy Benefit Managers
February 11, 2026
News
PBM Markets for Medicare Part D or Medicaid Are Highly Concentrated in Nearly Every State
February 6, 2026
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
White Paper
Hidden Profits? How Accounting Conventions and Vertical Consolidation Can Obscure PBM Profitability
January 22, 2026
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Perspective
Benchmarking Drug Prices to Inflation Overlooks What Truly Matters: Value
December 22, 2025
Featured Experts: William Padula, PhD
Evidence Base
The Value of Earlier Initiation of Anti-Amyloid Therapy for Alzheimer’s Disease
December 4, 2025
Featured Experts: Jack M. Chapel, PhD
Perspective
Assessing the Case Against Direct-to-Consumer Drug Advertisements
November 14, 2025
Featured Experts: Neeraj Sood, PhD
Perspective
Federally Fueled Hospital Drug Sales Must Be Reformed
November 14, 2025
Featured Experts: Ryan Long, Karen Mulligan, PhD
News
White House Move to Expand Obesity Drug Access Informed by Schaeffer Research
November 10, 2025
Comment Letter
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”
October 21, 2025
Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD